15926423062  

产品展厅

ML228
  • 品牌:TargetMol
  • 产地:China
  • 型号:1mg
  • 货号:T7836
  • cas:1357171-62-0
  • 价格: ¥536/支
  • 发布日期: 2023-02-21
  • 更新日期: 2024-04-15
产品详请
产地 China
品牌 TargetMol
货号 T7836
用途范围 Research Grade
纯度 >98%%
CAS编号 1357171-62-0
规格 1mg
是否进口
产品描述
ML228 is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 μM. ML228 potently activates HIF in vitro as well as its downstream target VEGF.


体外活性

ML228 represents a novel chemotype available to the research community for the study of HIF activation and its therapeutic potential. Not only is the compound substantially different in structure from known HIF activators, ML228 lacks the acidic functional group almost universally present in PHD inhibitors, which may be important for certain disease applications[1][2].


体内活性
ML228 (injection; 1 μg/kg; 7 days) treatments following spinal cord injury (SCI) improves the local hypoxic ischemia environment, reduces SCI secondary injury and promotes the recovery of neurological function[3].


Cas No.
1357171-62-0


分子式
C27H21N5


分子量
415.49


参考文献
[1]Chen H, et al. Effect of hypoxia-inducible factor-1/vascular endothelial growth factor signaling pathway on spinal cord injury in rats.Exp Ther Med. 2017 Mar;13(3):861-866.
[2]Theriault JR, et al. Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway. Bioorg Med Chem Lett. 2012 Jan 1;22(1):76-81.
[3]Theriault JR, et al. Discovery of a Small Molecule Activator of the Hypoxia Inducible Factor Pathway. Probe Reports from the NIH Molecular Libraries Program.


储存和溶解度
DMSO:30 mg/mL (72.2 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years


Note
For research use only .

< 返回前一个页面 >





联系方式
手机:15926423062
手机访问官网

15926423062

武汉科斯坦生物科技有限公司 版权所有(C)2024  XML 技术支持: 盖德化工网   食品商务网  

武汉科斯坦生物科技有限公司